Institute of Neuroimmunology and Clinical MS Research, University Medical Center Hamburg, Hamburg, Germany.
PLoS One. 2011;6(10):e26255. doi: 10.1371/journal.pone.0026255. Epub 2011 Oct 17.
Patient involvement into medical decisions as conceived in the shared decision making method (SDM) is essential in evidence based medicine. However, it is not conclusively evident how best to define, realize and evaluate involvement to enable patients making informed choices. We aimed at investigating the ability of four measures to indicate patient involvement. While use and reporting of these instruments might imply wide overlap regarding the addressed constructs this assumption seems questionable with respect to the diversity of the perspectives from which the assessments are administered.
The study investigated a nested cohort (N = 79) of a randomized trial evaluating a patient decision aid on immunotherapy for multiple sclerosis. Convergent validities were calculated between observer ratings of videotaped physician-patient consultations (OPTION) and patients' perceptions of the communication (Shared Decision Making Questionnaire, Control Preference Scale & Decisional Conflict Scale).
OPTION reliability was high to excellent. Communication performance was low according to OPTION and high according to the three patient administered measures. No correlations were found between observer and patient judges, neither for means nor for single items. Patient report measures showed some moderate correlations.
Existing SDM measures do not refer to a single construct. A gold standard is missing to decide whether any of these measures has the potential to indicate patient involvement.
Pronounced heterogeneity of the underpinning constructs implies difficulties regarding the interpretation of existing evidence on the efficacy of SDM. Consideration of communication theory and basic definitions of SDM would recommend an inter-subjective focus of measurement.
Controlled-Trials.com ISRCTN25267500.
在循证医学中,患者参与医学决策的理念,正如在共同决策方法(SDM)中所设想的那样,是至关重要的。然而,如何最好地定义、实现和评估参与度,以使患者能够做出明智的选择,这一点还没有明确的结论。我们旨在调查四种衡量标准指示患者参与度的能力。虽然这些工具的使用和报告可能暗示了它们在解决问题的结构方面存在广泛的重叠,但就评估的多样性而言,这一假设似乎值得怀疑。
该研究调查了一项随机试验的嵌套队列(N=79),该试验评估了一种用于多发性硬化症免疫治疗的患者决策辅助工具。对录像医患咨询的观察者评分(OPTION)和患者对沟通的感知(共同决策问卷、控制偏好量表和决策冲突量表)之间的收敛效度进行了计算。
OPTION 的可靠性为高到极好。根据 OPTION,沟通表现较低,但根据三种患者管理措施,沟通表现较高。观察者和患者评判者之间没有发现任何相关性,无论是平均值还是单项。患者报告措施显示出一些中度相关性。
现有的 SDM 衡量标准并未涉及单一的结构。缺乏黄金标准来决定这些衡量标准中的任何一个是否有潜力指示患者的参与度。
所依据的结构的明显异质性意味着在解释关于 SDM 有效性的现有证据时存在困难。考虑沟通理论和 SDM 的基本定义,建议将测量的重点放在主体间性上。
controlled-trials.com ISRCTN25267500。